Exchange: NASDAQ·Updated 07:34 PM EDT
PAHC logo

PAHCPhibro Animal Health Corp. - Ordinary Shares - Class A

$33.86
$0.81
(2.45%)
Today
Closed $33.86
$0.00
(0.00%)
After Hours
EarningsAug 26
Mkt Cap$1.34B
Vol179,458.00
News
all
press releases
GMED Stock Surges 43.6% in a Year: What's Driving the Rally?
Globus Medical's 43.6% one-year rally is fueled by strong growth across both business segments, rising technology adoption and a debt-free balance sheet.
Zacks
More News
Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now
ALHC's AI and automation are boosting margins and efficiency, but CMS risk model changes and revenue timing cloud near-term earnings visibility.
Zacks
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
ABT tops Q2 earnings and revenue estimates and lifts 2026 EPS guidance, while Medical Devices and Cancer Diagnostics fuel growth despite Nutrition weakness.
Zacks
Reasons to Retain Abbott Stock in Your Portfolio for Now
ABT is banking on emerging-market pharmaceutical growth and innovation in Nutrition, but macro pressures and currency swings remain key challenges.
Zacks
IART Stock Surges 52.1% in a Year: What's Driving the Rally?
Integra LifeSciences has climbed 52.1% in a year as growth across both segments, improved execution and transformation efforts continue to boost results.
Zacks
Is This the Right Time to Hold MYGN Stock in Your Portfolio?
Myriad Genetics expands its testing portfolio and advances its Cancer Care Continuum strategy. Can reimbursement risks and cost pressures temper growth?
Zacks
How Pet Healthcare Could Shape Chewy's Future Growth & Profitability?
CHWY is expanding its healthcare platform through Vet Care and Modern Animal to drive customer growth and long-term profitability.
Zacks
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Can Cost & Simplicity Program Keep Expanding Central Garden's Margins?
CENT is improving efficiency through cost discipline, simplification and operational changes that support long-term profitability.
Zacks
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?
ZBH is banking on knee growth, robotics and restructuring to drive results, but can macro pressures and competition limit the upside?
Zacks
<
1
2
...
>

Advertisement|Remove ads.